Efficacy and tolerability of combination treatments for major depression: antidepressants plus second-generation antipsychotics vs. esketamine vs. lithium

GH Vázquez, A Bahji, J Undurraga… - Journal of …, 2021 - journals.sagepub.com
Background: Successful treatment of major depressive disorder (MDD) can be challenging,
and failures (" treatment-resistant depression"[TRD]) are frequent. Steps to address TRD …

Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials

JG Borges-Vieira, CKS Cardoso - Nutritional neuroscience, 2023 - Taylor & Francis
Objectives This systematic review aimed to evaluate the efficacy of B vitamins and vitamin D
therapy in improving the standard treatment of depression and anxiety disorders. We also …

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau …

RW Lam, SH Kennedy, C Adams… - The Canadian …, 2024 - journals.sagepub.com
Résumé Contexte Le Réseau canadien pour les traitements de l'humeur et de l'anxiété
(CANMAT) a publié les dernières lignes directrices cliniques pour le traitement du trouble …

Psychopharmaka

MJ Lohse, J Seifert, S Bleich - Arzneiverordnungs-Report 2021, 2021 - Springer
Zusammenfassung Auf einen Blick Zusammenfassung Mit weit über 2 Milliarden DDD
stellen die Psychopharmaka eine der größten Arzneimittelgruppen dar. Dabei sind die seit …

Sex differences in responses to antidepressant augmentations in treatment-resistant depression

C Moderie, N Nuñez, A Fielding… - International Journal …, 2022 - academic.oup.com
Background Women are nearly twice as likely as men to suffer from major depressive
disorder. Yet, there is a dearth of studies comparing the clinical outcomes of women and …

Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?

AS de Miranda, JLVM de Barros… - Expert Opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction: Neurotrophin-3 (NT-3) is thought to play a role in the
neurobiological processes implicated in mood and anxiety disorders. NT-3 is a potential …

Effect of severity of depression on augmentation of antidepressant medication in young adults with depression

P Lampela, A Tanskanen, M Lähteenvuo… - Acta psychiatrica …, 2024 - Wiley Online Library
Background Antipsychotics (AP) have been used to augment antidepressant (AD)
medication in treatment‐resistant depression. In this study we examined factors (including …

Treatment-Resistant Depression in Older Adults

DC Steffens - New England Journal of Medicine, 2024 - Mass Medical Soc
Key Clinical Points Treatment-Resistant Depression in Older Adults Treatment-resistant
depression is common in older adults with depression and is associated with several …

[HTML][HTML] Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: a nationwide cohort study

M Lähteenvuo, H Taipale, A Tanskanen… - Journal of Affective …, 2022 - Elsevier
Objective Investigate incidence, risk factors and courses of treatment for treatment-resistant
depression (TRD) in primary and special healthcare. Methods All patients identified from …

Effectiveness of aerobic and resistance exercise in cancer survivors with depression: a systematic review and meta-analysis of randomized controlled trials

CYJ Law, THJ Yu, T Chen - Journal of Psychosomatic Research, 2023 - Elsevier
Objective AE and RE have been found to be effective for depressive symptoms. However, a
systematic review and meta-analysis of studies examining the effectiveness of exercises for …